π Introduction
βοΈ Obesity is a chronic, complex condition characterised by excessive accumulation of body fat.
It increases the risk of cardiovascular disease, type 2 diabetes, cancers, and premature mortality.
π It results from an interaction of genetic, behavioural, environmental, and metabolic factors.
Understanding its causes, features, diagnostics, and management is essential for effective care.
1οΈβ£ Causes of Obesity
- 𧬠Genetic Factors: Influence metabolism, appetite regulation, and fat storage; certain genes predispose to weight gain.
- π Dietary Habits: High-calorie diets, processed foods, sugary drinks, and fast food drive positive energy balance.
- ποΈ Physical Inactivity: Sedentary lifestyle (desk jobs, technology reliance) reduces energy expenditure.
- π¦ Endocrine Disorders: Hypothyroidism, Cushingβs syndrome, PCOS can contribute to weight gain.
- π Medications: Antidepressants, antipsychotics, corticosteroids, antiepileptics may cause weight gain.
- π§ Psychosocial Factors: Stress, depression, anxiety can trigger overeating or binge eating.
- π΄ Sleep Deprivation: Alters ghrelin/leptin β β appetite and caloric intake.
- π· Socioeconomic Factors: Limited access to healthy food, exercise facilities, and healthcare increases risk.
2οΈβ£ Clinical Features
- π Body Mass Index (BMI):
- Class I: 30β34.9
- Class II: 35β39.9
- Class III: β₯40 (morbid obesity)
- π Waist Circumference: Central obesity >40 in (men) or >35 in (women) β β metabolic risk.
- β€οΈ Comorbidities: Hypertension, type 2 diabetes, dyslipidaemia, NAFLD, OSA, osteoarthritis, cancers (breast, colon).
- π€ Physical Symptoms: Fatigue, breathlessness, joint pain, reduced mobility.
- π§ Psychological Impact: Depression, low self-esteem, social stigma, isolation.
3οΈβ£ Diagnostic Evaluation
- βοΈ BMI calculation: Weight (kg) Γ· height (mΒ²); β₯30 = obese.
- π Waist-to-Hip Ratio: Detects central obesity, stronger link with CVD.
- π§ͺ Blood tests:
- 𧬠Lipid profile β dyslipidaemia.
- π©Έ Fasting glucose / HbA1c β screen for diabetes.
- π¦ TFTs β rule out hypothyroidism.
- π· LFTs β assess for NAFLD.
- β‘ Hormonal assays β PCOS, Cushingβs.
- π΄ Sleep Studies: If symptoms suggest obstructive sleep apnoea.
4οΈβ£ Management β Multidisciplinary Approach
- π₯¦ Lifestyle Interventions (first-line)
- π Dietary Changes: Calorie deficit diet; β fruit/veg, lean protein, whole grains; β sugar, processed foods, saturated fats.
- π Physical Activity: β₯150 min/week of moderate exercise + resistance training.
- π§ Behavioural Therapy: CBT for eating behaviours, stress management, relapse prevention.
- π Pharmacological Therapy
- Orlistat β reduces fat absorption (GI side effects common).
- GLP-1 agonists (e.g., Liraglutide, Semaglutide) β appetite suppression + weight loss.
- Phentermine/Topiramate β appetite suppression (US-licensed).
- Metformin β useful in diabetes/insulin resistance, modest weight benefit.
- πͺ Surgical Interventions
- Indications: BMI β₯40, or β₯35 with comorbidities, and failure of conservative therapy.
- Procedures:
- Gastric bypass β reduces intake & absorption.
- Gastric sleeve β reduces stomach size & appetite hormones.
- Adjustable gastric banding β restricts stomach capacity.
- Requires lifelong follow-up, nutritional supplementation, and psychological support.
- π€ Psychological & Social Support
- Counselling β addresses body image, mood, emotional eating.
- Support groups β peer motivation and accountability.
π‘ Teaching Pearl
Obesity is not simply excess weight but a chronic disease.
Effective management requires a holistic, patient-centred, long-term approach addressing lifestyle, medical, and psychological needs.
π― Even modest weight loss (5β10% of body weight) leads to significant improvements in metabolic health.